Log in to save to my catalogue

Muscle‐specific gene editing improves molecular and phenotypic defects in a mouse model of myotonic...

Muscle‐specific gene editing improves molecular and phenotypic defects in a mouse model of myotonic...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_93bb18d30e7d4e9b8459dde9f5c067fe

Muscle‐specific gene editing improves molecular and phenotypic defects in a mouse model of myotonic dystrophy type 1

About this item

Full title

Muscle‐specific gene editing improves molecular and phenotypic defects in a mouse model of myotonic dystrophy type 1

Publisher

United States: John Wiley & Sons, Inc

Journal title

Clinical and translational medicine, 2025-02, Vol.15 (2), p.e70227-n/a

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Background
Myotonic dystrophy type 1 (DM1) is a genetic multisystemic disease, characterised by pleiotropic symptoms that exhibit notable variability in severity, nature and age of onset. The genetic cause of DM1 is the expansion of unstable CTG‐repeats in the 3′ untranslated region (UTR) of the DMPK gene, resulting in the accumulation of toxic...

Alternative Titles

Full title

Muscle‐specific gene editing improves molecular and phenotypic defects in a mouse model of myotonic dystrophy type 1

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_93bb18d30e7d4e9b8459dde9f5c067fe

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_93bb18d30e7d4e9b8459dde9f5c067fe

Other Identifiers

ISSN

2001-1326

E-ISSN

2001-1326

DOI

10.1002/ctm2.70227

How to access this item